Molecure (WAR:MOC) Other Stockholders Equity: zł0.03 Mil (As of Sep. 2025)


WAR:MOC Molecure SA WAR:MOC
30 GF Score
Price zł5.92
! 3 Warning Signs
View Full Analysis

What is Molecure Other Stockholders Equity?

Molecure WAR:MOC +4.41% 30 Other Stockholders Equity is zł0.03 Mil as of Sep. 2025. GuruFocus rates WAR:MOC with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

Molecure's Other Stockholders Equity for the quarter that ended in Sep. 2025 was zł0.03 Mil.

Molecure's quarterly Other Stockholders Equity declined from Mar. 2025 (zł4.08 Mil) to Jun. 2025 (zł0.03 Mil) and declined from Jun. 2025 (zł0.03 Mil) to Sep. 2025 (zł0.03 Mil).

Molecure's annual Other Stockholders Equity declined from Dec. 2022 (zł0.49 Mil) to Dec. 2023 (zł0.04 Mil) but then increased from Dec. 2023 (zł0.04 Mil) to Dec. 2024 (zł4.09 Mil).

Molecure Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Molecure's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecure Other Stockholders Equity Chart

Molecure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 2.97 0.49 0.04 4.09

Molecure Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 4.09 4.08 0.03 0.03
WAR:MOC
30GF Score
Molecure SA WAR:MOC
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecure Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of zł0.03 Mil mean?
Molecure (WAR:MOC) has a Other Stockholders Equity of zł0.03 Mil as of Sep. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Molecure and its competitors.
Is Molecure's Other Stockholders Equity too high?
Molecure's current Other Stockholders Equity is zł0.03 Mil. Overall, Molecure has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Molecure's Other Stockholders Equity compare to VRTX and REGN?
Molecure's Other Stockholders Equity of zł0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Molecure and its competitors. Molecure's current Other Stockholders Equity is zł0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecure stock overvalued right now?
Molecure (WAR:MOC) has a current Other Stockholders Equity of zł0.03 Mil. The current Other Stockholders Equity is zł0.03 Mil. Molecure's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Molecure (WAR:MOC), the current Other Stockholders Equity is zł0.03 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecure Business Description

Other Exchanges 1B1:Germany
Address Zwirki i Wigury 101, Warsaw, POL, 02-089
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
30GF Score

Get the complete analysis for WAR:MOC

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł5.92
Price